D. Hammerschmidt

发表

Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations

Frances P Lawrenz, Judy Illes, Joel G Fletcher, 2008, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

Dealing With the Long-Term Social Implications of Research

C. Grady, C. Levine, J. Sugarman, 2011, The American journal of bioethics : AJOB.

Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis

G. Vercellotti, H. Jacob, D. Hammerschmidt, 1982 .

Aggregation, chemotaxis, and chemiluminescence of canine granulocytes

P. Flynn, H. Redl, G. Schlag, 1983, Inflammation.

Ibuprofen inhibits granulocyte responses to inflammatory mediators

P. Flynn, G. Vercellotti, D. Weisdorf, 1984, Inflammation.

Synergy among agents inhibiting granulocyte aggregation

P. Flynn, H. Jacob, D. Hammerschmidt, 1982, Inflammation.

Influence of dietary omega-3 fatty acids on granulocyte function

D. Weisdorf, C. Lammi-Keefe, H. Jacob, 1982, Inflammation.

Inhibition of granulocyte function by steroids is not limited to corticoids

P. Silberstein, D. Hammerschmidt, H. Lamche, 1988, Inflammation.

Chronic Myelogenous Leukemia: Development of Blast Crisis With Both Lymphoid and Myeloid Features

T. Lebien, P. Flynn, D. Weisdorf, 1983 .

Complement activation and neutropenia occurring during cardiopulmonary bypass.

D. Stroncek, C. Lammi-Keefe, D. Nicoloff, 1981, The Journal of thoracic and cardiovascular surgery.

Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury.

D. Weisdorf, H. Jacob, D. Hammerschmidt, 1981, The Journal of laboratory and clinical medicine.

Complement-mediated granulocyte activation and down-regulation during hemodialysis

D. Hammerschmidt, P. Craddock, 1984 .

Special Scrutiny: A Targeted Form of Research Protocol Review

C. Grady, R. Faden, C. Levine, 2004, Annals of Internal Medicine.

Leukocytes and the risk of ischemic diseases.

J. Dormandy, E. Ernst, D. Hammerschmidt, 1987, JAMA.

Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.

D. Stroncek, P. Keshaviah, D. Hammerschmidt, 1984, The Journal of laboratory and clinical medicine.

Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis.

A. Dalmasso, R. Kronenberg, H. Jacob, 1978, Blood.

It's as simple as black and white! Race and ethnicity as categorical variables.

D. Hammerschmidt, 1999, The Journal of laboratory and clinical medicine.

Historical perspective and clinical implications of the Pelger‐Huet cell

J. Cunningham, G. Vercellotti, M. Patnaik, 2009, American journal of hematology.

Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.

H. Jacob, D. Hammerschmidt, P. Craddock, 1980, Blood.

Fatal complement-induced leukostasis after diatrizoate injection. Principles of clinicopathologic diagnosis.

H. Jacob, D. Hammerschmidt, A. McCall, 1983, JAMA.

Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.

G. Vercellotti, H. Jacob, D. Hammerschmidt, 1982, Blood.

Chemotactic and phagocytic responses of human alveolar macrophages to activated complement components

H. Verbrugh, R. Nelson, P. Peterson, 1984, Infection and immunity.

Leukocytes in lung injury.

D. Hammerschmidt, 1983, Chest.

Platelets and the environment.

D. Hammerschmidt, 1982, JAMA.

Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity

David D. Thomas, P. Silberstein, H. Jacob, 1990, Inflammation.

Endogenous and Exogenous Adenosine Inhibit Granulocyte Aggregation Without Altering the Associated Rise in Intracellular Calcium Concentration

D. Hammerschmidt, K. Skubitz, N. Wickham, 1988 .

Endogenous and exogenous adenosine inhibit granulocyte aggregation without altering the associated rise in intracellular calcium concentration.

D. Hammerschmidt, K. Skubitz, N. Wickham, 1988, Blood.

Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down- regulation

D. Hammerschmidt, K. Skubitz, 1986 .

Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulation.

D. Hammerschmidt, K. Skubitz, 1986, Blood.

Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.

J. August, D. Hammerschmidt, K. Skubitz, 1981, The Journal of clinical investigation.

Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.

J. White, H. Jacob, D. Hammerschmidt, 1979, The Journal of clinical investigation.

Post-Prandial Chylomicron Creaming, C-Reactive Protein and Enhanced Complement Activation

G. Vercellotti, H. Jacob, D. Hammerschmidt, 1993 .

Prometheus.

D. Hammerschmidt, Ko van den Bosch, 2021, The Journal of laboratory and clinical medicine.

Augmentation by platelets of granulocyte aggregation in response to chemotaxins: studies utilizing an improved cell preparation technique

H. Redl, G. Schlag, D. Hammerschmidt, 1983 .

Augmentation by platelets of granulocyte aggregation in response to chemotaxins: studies utilizing an improved cell preparation technique.

H. Redl, G. Schlag, D. Hammerschmidt, 1983, Blood.

Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage.

H. Jacob, D. Hammerschmidt, O. Yamada, 1979, Seminars in hematology.

ASSOCIATION OF COMPLEMENT ACTIVATION AND ELEVATED PLASMA-C5a WITH ADULT RESPIRATORY DISTRESS SYNDROME Pathophysiological Relevance and Possible Prognostic Value

L. J. Weaver, H. Jacob, L. Hudson, 1980, The Lancet.

Complement-induced granulocyte aggregation in vivo.

H. Jacob, D. Hammerschmidt, P. Craddock, 1981, The American journal of pathology.

Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis

D. Stroncek, G. Vercellotti, H. Jacob, 1992 .

Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis.

D. Stroncek, G. Vercellotti, H. Jacob, 1992, Blood.

Effects of ibuprofen on chemotactic peptide-receptor binding and granulocyte response.

D. Hammerschmidt, K. Skubitz, 1986, Biochemical pharmacology.

Complement activation by trichophyton rubrum.

D. Hammerschmidt, M. Dahl, J. Swan, 1983, The Journal of investigative dermatology.

Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states.

H. Jacob, C. Greenberg, D. Hammerschmidt, 1981, The Journal of laboratory and clinical medicine.

A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function.

R. King, D. Hammerschmidt, L. Furcht, 1980, JAMA.

Breath hydrogen and lactose intolerance

D. Hammerschmidt, 2004 .

Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosis.

H. Jacob, C. Greenberg, D. Hammerschmidt, 1979, Transactions of the Association of American Physicians.

Leukocyte abnormalities in renal failure and hemodialysis.

N. Kay, L. Raij, D. Hammerschmidt, 1985, Seminars in nephrology.

Chemotaxigenesis by cell surface components of Staphylococcus aureus

J. Verhoef, P. Peterson, P. Quie, 1979, Infection and immunity.

Symptoms and activation of granulocytes and complement with two dialysis membranes.

H. Jacob, L. Boxer, D. Hammerschmidt, 1983, Kidney international.

Leukemia in donor cells after allogeneic hematopoietic stem cell transplant

D. Hammerschmidt, C. Brunstein, BA Hirsch, 2002, Bone Marrow Transplantation.

Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.

H. Verbrugh, J. Verhoef, J. Spika, 1982, The Journal of infectious diseases.

Lymphocyte aggregation in response to adrenergic stimulation.

M. Hušák, H. Jacob, D. Hammerschmidt, 1988, Blood.

Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock.

H. Jacob, D. Hammerschmidt, P. Coppo, 1982, JAMA.

Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lung.

H. Jacob, D. Hammerschmidt, 1981, JAMA.

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

J. White, H. Jacob, D. Hammerschmidt, 1977, The Journal of clinical investigation.

Sodium morrhuate stimulates granulocytes and damages erythrocytes and endothelial cells: probable mechanism of an adverse reaction during sclerotherapy.

D. Stroncek, G. Vercellotti, H. Jacob, 1985, The Journal of laboratory and clinical medicine.

Postoperative severe microangiopathic hemolytic anemia associated with a giant hepatic cavernous hemangioma

T. Sielaff, A. Humar, J. D’Cunha, 2005, Journal of Gastrointestinal Surgery.

About the cover illustration.

Dale E Hammerschmidt, D. Hammerschmidt, 2005, The Journal of laboratory and clinical medicine.

Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients.

Y. Ploysongsang, E. Miller, J. Crissman, 1983, Annals of internal medicine.

The Limitations of “Vulnerability” as a Protection for Human Research Participants

Jeremy Sugarman, Carol Levine, C. Grady, 2004 .

Mechanisms of Vascular Damage in Gout and Oxalosis: Crystal Induced, Granulocyte Mediated, Endothelial Injury

R. Verwilghen, M. Boogaerts, H. Jacob, 1983, Thrombosis and Haemostasis.

Complement-induced granulocyte aggregation: an unsuspected mechanism of disease.

M. J. Moore, H. L. Bleich, H. Jacob, 1980, The New England journal of medicine.

About the cover illustration: Curcuma longa: Culinary turmeric

D. Hammerschmidt, 1997 .

Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.

G. Vercellotti, P. Huh, D. Hammerschmidt, 1988, The Journal of laboratory and clinical medicine.

The scientific mind at work (and play)

H. Jacob, D. Hammerschmidt, 1981, JAMA.

Amniotic fluid activates complement. A role in amniotic fluid embolism syndrome?

J. Williams, P. Ogburn, D. Hammerschmidt, 1984, The Journal of laboratory and clinical medicine.

Karl Landsteiner: blood groups foreseen?

D. Hammerschmidt, 2000, The Journal of laboratory and clinical medicine.

Pancytopenia due to hemophagocytic syndrome as the presenting manifestation of babesiosis

J. L. Goodman, R. Hurley, D. Hammerschmidt, 1995, American journal of hematology.

Permeability studies in a hypovolemic traumatic shock model: comparison of Ringer's lactate and albumin as volume replacement fluids.

H. Redl, G. Schlag, D. Hammerschmidt, 1989, Resuscitation.

Thrombocytopenia during Heparin Therapy

D. Hammerschmidt, L. Hanauer, R. B. Babcock, 1976 .

Nonsurgical splenectomy.

K. Amplatz, W. Castañeda-Zúñiga, D. Hammerschmidt, 1977, AJR. American journal of roentgenology.

Inhibition by halothane, but not by isoflurane, of oxidative response to opsonized zymosan in whole blood

H. Redl, G. Schlag, D. Hammerschmidt, 1989, Inflammation.

Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals

C. Grady, E. Emanuel, K. Getz, 2004, Annals of Internal Medicine.

Spontaneous rupture of the esophagus. Report of a case with a benign presentation and spontaneous resolution.

D. Hammerschmidt, S. Silvis, V. Badertscher, 1973, The American journal of gastroenterology.

Hemolytic anemia in protoporphyria: Possible precipitating role of liver failure and photic stress

J. Rank, J. Bloomer, N. Key, 1992, American journal of hematology.

Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization.

G. Weissmann, I. Goldstein, H. Jacob, 1981, Archives of internal medicine.

Digital integration of granulocyte aggregation responses

D. Weisdorf, D. Hammerschmidt, P. Craddock, 1980, Inflammation.

Hyperacute pulmonary vasculitis in rabbits receiving prolonged infusions of activated complement

N. Ratliff, H. Jacob, D. Hammerschmidt, 1983, Inflammation.

Of lungs and leukocytes.

D. Hammerschmidt, 1980, JAMA.

Maternal Ehlers-Danlos syndrome type X. Successful management of pregnancy and parturition.

D. Hammerschmidt, R. V. Van Tassel, J. McKenna, 1982, JAMA.

Fat Embolism Prophylaxis with Corticosteroids

Y. Ploysongsang, E. Miller, J. Crissman, 2020 .

Protein loss induced by complement activation during peritoneal dialysis.

J. Moore, D. Hammerschmidt, G. Anderson, 1984, Kidney international.

Activated Granulocytes as Mediators of Organ Failure in Shock

D. Hammerschmidt, 1987 .

Perfluorocarbons as Blood Substitutes: Limitation of Complement Activation in the Control of Adverse Reactions

G. Vercellotti, D. Hammerschmidt, 1986 .

A restless investigator.

D. Hammerschmidt, 2006, Journal of Laboratory and Clinical Medicine.

Behaviour of platelets and β-thromboglobulin

D. Hammerschmidt, P. Ivanovich, H. Klinkmann, 1993 .

Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des‐Arg 9 ‐bradykinin after contact activation

A. Adam, G. Molinaro, D. Hammerschmidt, 2002, Transfusion.

Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size.

P. Flynn, G. Vercellotti, D. Weisdorf, 1984, Inflammation.

A Response to Commentators on “The Limitations of ‘Vulnerability’ as a Protection for Human Research Participants”

Jeremy Sugarman, Carol Levine, C. Grady, 2004, The American journal of bioethics : AJOB.

Claude Bernard (1813–1878) *

D. Hammerschmidt, 2005 .

[Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].

C. Werning, D. Hammerschmidt, H. Kaiser, 1978, Die Medizinische Welt.

Rudolf Virchow.

D. Hammerschmidt, 2006, Journal of Laboratory and Clinical Medicine.

Immunological Biocompatibility in Blood Substitutes

G. Vercellotti, D. Hammerschmidt, 1985, International anesthesiology clinics.

Odysseus and the sirens

D. Hammerschmidt, 2004 .

Quantitative assessment of leukostasis in experimental hypovolemic-traumatic shock.

H. Redl, G. Schlag, D. Hammerschmidt, 1984, Acta chirurgica Scandinavica.

Development of a simple radioimmunoassay for human C3a

H. Redl, G. Schlag, D. Hammerschmidt, 1988, Inflammation.

Activated Granulocytes in the Lung Injury of Shock: Implications for Therapy

D. Hammerschmidt, 1986 .

This month in J Lab Clin Med: Issue highlights for July 2000

D. Hammerschmidt, 2000 .

Cholecystitis as the presenting manifestation of acute myeloid leukemia

A. Ashrani, D. Hammerschmidt, J. Coad, 2002, American journal of hematology.

THERAPEUTIC RAMIFICATIONS OF THE INTERACTION OF COMPLEMENT, GRANULOCYTES, AND PLATELETS IN THE PRODUCTION OF ACUTE LUNG INJURY *

P. Flynn, G. Vercellotti, D. Weisdorf, 1982, Annals of the New York Academy of Sciences.

Hemodynamic profile of adverse clinical reactions to Fluosol‐DA 20%

G. Vercellotti, D. Hammerschmidt, K. Tremper, 1984, Critical care medicine.

Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations.

G. Vercellotti, D. Hammerschmidt, Gregory M. Vercellotti, 1988, Biomaterials, artificial cells, and artificial organs.

Clinical utility of complement anaphylatoxin assays.

D. Hammerschmidt, 1986, Complement.

Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage.

F. Cerra, G. Vercellotti, P. Ogburn, 1985, Obstetrics and gynecology.

[The practice of hypertensive therapy using a beta receptor blocker. A multicentric study using 15 mg Visken].

D. Hammerschmidt, D. Welzel, J. Rosenthal, 1977, Die Medizinische Welt.

Institutional Review Board (IRB) review lacks impact on the readability of consent forms for research.

D. Hammerschmidt, Moira A. Keane, 1992, The American journal of the medical sciences.

Revising the research record

N. Goodman, D. Hammerschmidt, A. Gross, 1996, The Lancet.

This month in J Lab Clin Med: Issue highlights for March 2005

D. Hammerschmidt, 2005 .

Aggregation, chemotaxis, and chemiluminescence of canine granulocytes. Studies utilizing improved cell preparation techniques.

P. Flynn, H. Redl, G. Schlag, 1983, Inflammation.

Requiring Consent vs. Waiving Consent for Medical Records Research: A Minnesota Law vs. the U.S. (HIPAA) Privacy Rule

B. Woodward, D. Hammerschmidt, 2003, Health Care Analysis.